2022 AUA preview: Dr. Krambeck on top research in BPH and urinary stones

Video

Amy Krambeck, MD, highlights 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting.

In this video, Amy Krambeck, MD, discusses 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting. Krambeck is a professor of Urology, Department of Urology, Northwestern University, Feinberg School of Medicine.

The following 6 abstracts are previewed:

1. LBA01-02 (Morsy, et al):Efficacy of Low-Power Thulium Laser Enucleation of Prostate Larger Than 80 Grams

2. LBA01-05 (Beltran, et al):Surgical Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement By Holmium Laser Enucleation of the Prostate Versus Transurethral Resection of the Prostate And Open Adenomectomy

3. LBA01-06 (Amparore, el):Long Term Follow-Up of an International Multicenter Prospective Study in Application of Temporary Implantable Nitinol Device (iTind) in Men With Lower Urinary Tract Symptoms for BPH

4. LBA02-04 (Yang, et al): Effect of Extracorporeal Shock Wave Lithotripsy Combined With Extracorporeal Physical Vibration Lithotripsy in the Treatment of Patients With Ureteral Calculi

5. LBA02-08 (Harper, et al): Risk Factors for Increased Stent-Associated Symptoms Following Ureteroscopy for Urinary Stones: Results From the Urinary Stone Disease Research Network (USDRN) Stents Study

6. LBA02-10 (Mookerji, et al): Assessing the Risks of A Positive Urine Culture in Uncomplicated Renal Colic Patients

Recent Videos
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
 Nicholas Zaorsky, MD, MS: Protecting kidney function after local renal cell carcinoma therapy
Nicholas van AS, MD, MBBCH: The case for SBRT as a standard of care for localized prostate cancer
Pierre Blanchard, MD, PhD: What can hydrogel space provide to optimal prostate cancer care?
Savita Dandapani, MD, PhD: Findings from the phase 2 SHARP trial
Related Content
© 2024 MJH Life Sciences

All rights reserved.